Fig. 4
From: Cessation of enzyme replacement therapy in Gaucher disease
Relative response by Patient 4 to β-glucosidase ERT and to its cessation. Percent change in platelets (PLT), hemoglobin (HGB), ACE, spleen volume, and liver volume on ERT (1.5 years) and off therapy (7 years). The patient received 60 U/kg/2 weeks of enzyme the first 6 months and then 15 U/kg/2 weeks for the next year while on ERT. His β-glucocerebrosidase genotype is N370S/N370S.
